Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

Eliquis (Apixaban) sold by Bristol Myers Squibb ... between 2025 and 2028 and this will be a huge opportunity for Indian generic drug manufacturers. This along with the current drug shortage ...